Algorithmiq develops quantum algorithms and software for drug discovery and pharmaceutical research, focusing on quantum-enhanced molecular simulation and optimization techniques to accelerate the development of new medicines by solving complex computational problems in chemistry and biology that are intractable for classical computers, founded by quantum computing and pharmaceutical industry experts.
Sabrina Maniscalco (Co-founder, CEO), Stefan Filipp (Co-founder, CTO)
Explore other quantum computing companies in similar categories or regions.
Information for Educational Purposes Only: All information about Algorithmiq is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of Algorithmiq's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.